IN2013MU02583A - - Google Patents

Info

Publication number
IN2013MU02583A
IN2013MU02583A IN2583MU2013A IN2013MU02583A IN 2013MU02583 A IN2013MU02583 A IN 2013MU02583A IN 2583MU2013 A IN2583MU2013 A IN 2583MU2013A IN 2013MU02583 A IN2013MU02583 A IN 2013MU02583A
Authority
IN
India
Prior art keywords
cefixime
salts
intermediates
hydrophobic substances
present
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Jain Girish
Venkataramana Naidu
Gupta Saurabh
Agarwal Amar
Srikanth Pattipati
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN2583MU2013 priority Critical patent/IN2013MU02583A/en
Publication of IN2013MU02583A publication Critical patent/IN2013MU02583A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2583MU2013 2013-08-05 2013-08-05 IN2013MU02583A (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2583MU2013 IN2013MU02583A (pl) 2013-08-05 2013-08-05

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2583MU2013 IN2013MU02583A (pl) 2013-08-05 2013-08-05

Publications (1)

Publication Number Publication Date
IN2013MU02583A true IN2013MU02583A (pl) 2015-06-12

Family

ID=54199327

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2583MU2013 IN2013MU02583A (pl) 2013-08-05 2013-08-05

Country Status (1)

Country Link
IN (1) IN2013MU02583A (pl)

Similar Documents

Publication Publication Date Title
JOP20180103A1 (ar) مركب صيدلاني
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
IN2014MN02598A (pl)
MX2012007806A (es) Composiciones farmaceuticas para administracion oral de peptidos de insulina.
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
MX348823B (es) Formulaciones estables de linaclotida.
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
PH12015501096A1 (en) Composition for immediate and extended release
MX2015010106A (es) Moduladores de la proteina activadora de 5-lipoxigenasa.
MX340147B (es) Composiciones farmacéuticas y nutracéuticas del ácido abscísico.
WO2015033302A3 (en) Fulvestrant compositions
UA116889C2 (uk) Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc)
IN2015DN03998A (pl)
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
PH12018500378B1 (en) Novel annelated phenoxyacetamides
IN2014DN10449A (pl)
MX2016006087A (es) Formulaciones de desintegracion rapida y metodos de uso.
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PH12016500577B1 (en) Piperazine derivatives and the use thereof as medicament
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
WO2014166836A8 (en) Growth hormone compound formulation
MX2021003908A (es) Polipeptidos de accion prolongada y metodos para su produccion y administracion.